Affordable Access

Publisher Website

Total recall: the role of PIDDosome components in neurodegeneration.

Authors
  • Volik, Pavel I1
  • Kopeina, Gelina S1
  • Zhivotovsky, Boris2
  • Zamaraev, Alexey V3
  • 1 Facuty of Medicine, MV Lomonosov Moscow State University, 119991 Moscow, Russia; Engelhardt Institute of Molecular Biology, RAS, 119991 Moscow, Russia.
  • 2 Facuty of Medicine, MV Lomonosov Moscow State University, 119991 Moscow, Russia; Engelhardt Institute of Molecular Biology, RAS, 119991 Moscow, Russia; Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, 17177 Stockholm, Sweden. Electronic address: [email protected]. , (Sweden)
  • 3 Facuty of Medicine, MV Lomonosov Moscow State University, 119991 Moscow, Russia; Engelhardt Institute of Molecular Biology, RAS, 119991 Moscow, Russia. Electronic address: [email protected].
Type
Published Article
Journal
Trends in molecular medicine
Publication Date
Dec 01, 2023
Volume
29
Issue
12
Pages
996–1013
Identifiers
DOI: 10.1016/j.molmed.2023.08.008
PMID: 37716905
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The PIDDosome is a multiprotein complex that includes p53-induced protein with a death domain 1 (PIDD1), receptor-interacting protein-associated ICH-1/CED-3 homologous protein with a death domain (RAIDD), and caspase-2, the activation of which is driven by PIDDosome assembly. In addition to the key role of the PIDDosome in the regulation of cell differentiation, tissue homeostasis, and organogenesis and regeneration, caspase-2, RAIDD and PIDD1 engagement in neuronal development was shown. Here, we focus on the involvement of PIDDosome components in neurodegenerative disorders, including retinal neuropathies, different types of brain damage, and Alzheimer's disease (AD), Huntington's disease (HD), and Lewy body disease. We also discuss pathogenic variants of PIDD1, RAIDD, and caspase-2 that are associated with intellectual, behavioral, and psychological abnormalities, together with prospective PIDDosome inhibition strategies and their potential clinical application. Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Report this publication

Statistics

Seen <100 times